Takeda Pharmaceutical Company Limited operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Takeda Pharmaceutical Company Limited with three other
companies in this sector in Japan:
Eisai Company Limited
sales of 547.92 billion Japanese Yen [US$5.26 billion]
of which 49%
was Pharmaceutical Business -Japan),
Daiichi Sankyo Company Limited
(986.45 billion Japanese Yen [US$9.47 billion]
of which 94%
was prescription drugs), and
Astellas Pharma Incorporated
(1.37 trillion Japanese Yen [US$13.18 billion]
of which 57%
Takeda Pharmaceutical Company Limited reported sales of ¥1.81 trillion (US$17.35 billion)
March of 2016.
a very small
increase of 1.7%
versus 2015, when the company's sales were ¥1.78 trillion.
Sales at Takeda Pharmaceutical Company Limited have increased during each of the previous five years
(and since 2011, sales have increased a total of 27%).